FDA Inspection 1272612 — CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services

CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services — FEI 1672092

The FDA completed an inspection of CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services on June 5, 2025 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)